The synergistic effects of betulin with acyclovir against herpes simplex viruses.

Betulin, a pentacyclic triterpenoid, was isolated from the bark of Betula papyrifera. The antiviral efficacies of betulin on herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) were evaluated using viral plaque reduction assays on Vero cells. The results indicate that betulin is active against both HSV-1 and HSV-2 infections with the 50% effective concentrations (EC(50)) of 0.40 and 4.15 microg/ml, respectively. The cytotoxicity of betulin was examined on Vero cells using a neutral red uptake assay. The 50% cytotoxic concentration (CC(50)) of betulin was 73.1 microg/ml. A synergistic antiviral effect between betulin and acyclovir (ACV) was determined by drug combination studies. Strong and moderate synergistic antiviral effects were observed for betulin and ACV against HSV-1 when the concentrations of ACV and betulin were higher than 0.068 and 0.4 microg/ml, respectively. At the concentrations lower than these, additive effect was found. Synergistic antiviral effects were also found against HSV-2 at higher concentrations than for HSV-1, i.e. 0.45 microg/ml of ACV combined with 8.4 microg/ml of betulin.

[1]  S. Wada,et al.  Screening of triterpenoids isolated from Phyllanthus flexuosus for DNA topoisomerase inhibitory activity. , 2001, Journal of natural products.

[2]  Geoffrey A. Cordell,et al.  Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis , 1995, Nature Medicine.

[3]  B. Matthews,et al.  Evidence of dual sites of action of dendrimers: SPL-2999 inhibits both virus entry and late stages of herpes simplex virus replication. , 2002, Antiviral research.

[4]  Jun Kato,et al.  Inhibitory effects of triterpenoids and sterols on human immunodeficiency virus-1 reverse transcriptase , 2001, Lipids.

[5]  J. Subak-Sharpe,et al.  The effect of triterpenoid compounds on uninfected and herpes simplex virus-infected cells in culture. III. Ultrastructural study of virion maturation. , 1988, The Journal of general virology.

[6]  R K Craig,et al.  Methods in molecular medicine. , 1987, British medical journal.

[7]  W. Rzeski,et al.  Differential effect of betulin and betulinic acid on cytokine production in human whole blood cell cultures. , 2003, Polish journal of pharmacology.

[8]  G. Tolstikov,et al.  Lupane triterpenes and derivatives with antiviral activity. , 2003, Bioorganic & medicinal chemistry letters.

[9]  K. Schmidt,et al.  Hepatitis B virus cell culture assays for antiviral activity. , 2000, Methods in molecular medicine.

[10]  J. Subak-Sharpe,et al.  The effect of triterpenoid compounds on uninfected and herpes simplex virus-infected cells in culture. I. Effect on cell growth, virus particles and virus replication. , 1985, The Journal of general virology.

[11]  T. Chou,et al.  Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. , 1984, Advances in enzyme regulation.

[12]  K. Lee,et al.  Anti-AIDS agents. 34. Synthesis and structure-activity relationships of betulin derivatives as anti-HIV agents. , 1998, Journal of medicinal chemistry.

[13]  O. Savinova,et al.  Antiviral activity of betulin, betulinic and betulonic acids against some enveloped and non-enveloped viruses. , 2003, Fitoterapia.

[14]  J. Subak-Sharpe,et al.  The effect of triterpenoid compounds on uninfected and herpes simplex virus-infected cells in culture. II. DNA and protein synthesis, polypeptide processing and transport. , 1986, The Journal of general virology.

[15]  K. Lee,et al.  3,28-Di-O-(dimethylsuccinyl)-betulin isomers as anti-HIV agents. , 2001, Bioorganic & medicinal chemistry letters.

[16]  K. Lee,et al.  Anti-AIDS agents. 32. Synthesis and anti-HIV activity of betulin derivatives. , 1998, Bioorganic & medicinal chemistry letters.

[17]  P. Griffiths,et al.  Herpes simplex virus latency and nucleoside analogues. , 1999, Antiviral research.

[18]  E. Clercq.  Antiviral drugs: current state of the art. , 2001, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[19]  R. Schinazi,et al.  Antiviral methods and protocols , 1999 .

[20]  D M Coen,et al.  Molecular mechanisms of antiviral resistance. , 1995, Antiviral research.